234 related articles for article (PubMed ID: 34455132)
1. SARM1-mediated wallerian degeneration: A possible mechanism underlying organophosphorus-induced delayed neuropathy.
Song M; Kang K; Song F
Med Hypotheses; 2021 Oct; 155():110666. PubMed ID: 34455132
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy.
Emerick GL; DeOliveira GH; dos Santos AC; Ehrich M
Chem Biol Interact; 2012 Sep; 199(3):177-84. PubMed ID: 22819951
[TBL] [Abstract][Full Text] [Related]
3. Elevated intracellular Ca
Song M; Kang K; Wang S; Zhang C; Zhao X; Song F
Toxicology; 2024 May; 504():153812. PubMed ID: 38653376
[TBL] [Abstract][Full Text] [Related]
4. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
[TBL] [Abstract][Full Text] [Related]
5. Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.
Loring HS; Thompson PR
Cell Chem Biol; 2020 Jan; 27(1):1-13. PubMed ID: 31761689
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
7. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
8. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
9. Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).
Richardson RJ; Fink JK; Glynn P; Hufnagel RB; Makhaeva GF; Wijeyesakere SJ
Adv Neurotoxicol; 2020; 4():1-78. PubMed ID: 32518884
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
11. Tri-ortho-cresyl phosphate induces axonal degeneration in chicken DRG neurons by the NAD+ pathway.
Sun YY; Wu YJ
Toxicol Lett; 2022 Jun; 363():77-84. PubMed ID: 35643292
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Localization of SARM1 in Acrylamide Intoxication Induces Mitophagy and Limits Neuropathy.
Wang S; Song M; Yong H; Zhang C; Kang K; Liu Z; Yang Y; Huang Z; Wang S; Ge H; Zhao X; Song F
Mol Neurobiol; 2022 Dec; 59(12):7337-7353. PubMed ID: 36171479
[TBL] [Abstract][Full Text] [Related]
13. Excitotoxicity upregulates SARM1 protein expression and promotes Wallerian-like degeneration of retinal ganglion cells and their axons.
Massoll C; Mando W; Chintala SK
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2771-80. PubMed ID: 23518770
[TBL] [Abstract][Full Text] [Related]
14. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration.
Alexandris AS; Lee Y; Lehar M; Alam Z; Samineni P; Tripathi SJ; Ryu J; Koliatsos VE
Exp Neurol; 2023 Jan; 359():114252. PubMed ID: 36244414
[TBL] [Abstract][Full Text] [Related]
15. Identification of the first noncompetitive SARM1 inhibitors.
Loring HS; Parelkar SS; Mondal S; Thompson PR
Bioorg Med Chem; 2020 Sep; 28(18):115644. PubMed ID: 32828421
[TBL] [Abstract][Full Text] [Related]
16. Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.
Henninger N; Bouley J; Sikoglu EM; An J; Moore CM; King JA; Bowser R; Freeman MR; Brown RH
Brain; 2016 Apr; 139(Pt 4):1094-105. PubMed ID: 26912636
[TBL] [Abstract][Full Text] [Related]
17. SARM1 can be a potential therapeutic target for spinal cord injury.
Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
[TBL] [Abstract][Full Text] [Related]
18. Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy.
Alexandris AS; Lee Y; Lehar M; Alam Z; McKenney J; Perdomo D; Ryu J; Welsbie D; Zack DJ; Koliatsos VE
J Neurotrauma; 2023 Aug; 40(15-16):1743-1761. PubMed ID: 36680758
[TBL] [Abstract][Full Text] [Related]
19. Deregulated mitochondrial quality control, the heel of Achilles in elucidating the role of autophagy in SARM1-mediated axon degeneration.
Wang S; Zhang Y; Song M; Zhao X; Song F
J Neurosci Res; 2024 Jan; 102(1):e25292. PubMed ID: 38284842
[TBL] [Abstract][Full Text] [Related]
20. The mitochondrial Nod-like receptor NLRX1 modifies apoptosis through SARM1.
Killackey SA; Rahman MA; Soares F; Zhang AB; Abdel-Nour M; Philpott DJ; Girardin SE
Mol Cell Biochem; 2019 Mar; 453(1-2):187-196. PubMed ID: 30191480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
